Immuneering CorporationIMRXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+3.5%
5Y CAGR+40.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+3.5%/yr
Annual compound
5Y CAGR
+40.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.6x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$17.30M+7.6%
2024$16.08M-4.1%
2023$16.76M+7.4%
2022$15.61M+88.7%
2021$8.27M+166.0%
2020$3.11M+14.8%
2019$2.71M-